Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

Clinical trial NCT03602820 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03602820
Sponsor: Genentech, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Inherited Retinal Dystrophy Due to RPE65 Mutations

Start date: 2015-06-01
Primary completion: 2030-01-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.